Skip to content

The clinical and cost-effectiveness of mindfulness based cognitive therapy (MBCT), optimal medical management (OMM) and its combination in the prevention of relapse in patients with recurrent depression.

The clinical and cost-effectiveness of mindfulness based cognitive therapy (MBCT), optimal medical management (OMM) and its combination in the prevention of relapse in patients with recurrent depression. - Mindfulness, medication and its combination for recurrent depression.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32669
Enrollment
400
Registered
2008-11-18
Start date
2009-01-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

major depressive disorder (recurrent) recurrent depression

Interventions

Combination of mindfulness based cognitive therapy (MBCT) and optimised medical management (OMM), OMM alone and MBCT alone.

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with major depressive disorder with at least three previous depressive episodes. Patients have been treated with a therapeutic dose of antidepressant medication over the last 6 months. Patients are currently either in full or partial remission.

Exclusion criteria

Exclusion criteria: Bipolar disorder Any primary psychotic disorder Clinically relevant neurological or other somatic illness Current alcohol or drug misuse Use of high dosage of benzodiazepines (>2 mg lorazepam equivalents daily) Recent Electro Convulsive Therapy

Design outcomes

Primary

MeasureTime frame
Primary outcome measure: risk of relapse or recurrence of depression defined by DSM-IV criteria as assessed by the Structured Clinical Interview for DSM-IV (SCID; First et al., 1996) and incremental cost-effectiveness ratio.

Secondary

MeasureTime frame
Secondary outcome measures: time to, duration and severity of relapse or recurrence as assessed by the Inventory of Depression Symptomatology Self Rated (IDS-SR; Rush et al., 1996), psychiatric comorbidity and quality of life.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)